Can GLP-1 generics fix India’s obesity epidemic, which goes beyond body size?

Can GLP-1 generics fix India’s obesity epidemic, which goes beyond body size?

👁 0 views
Mukta Dhond at her residence in Khar, Mumbai.

Mukta Dhond at her residence in Khar, Mumbai.
| Photo Credit: Emmanual Yogini

Mukta Dhond has a brand new month-to-month ritual. “I have to take my 20 pairs of jeans to the tailor for size alterations,” says the 49-year-old Mumbai-based tv producer.

A single mom who has been battling obesity for a big a part of her life, she determined it was time for a change when throughout a Scotland trip along with her toddler son in 2024, she was left gasping after a steep climb. Dhond was a pre-diabetic then. “He would run up the hills and I would be far behind. I realised it was time to change things,” she remembers. From weighing 117 kg in March 2025, when she began her GLP-1 journey with Ozempic, Dhond is at 95 kg at this time. She factors to a sense of reinvention and liberation — a “game-changer”, in her phrases.

Scroll to Top